Evidence map›Paper›PMID 40137722›Full record

ArticlePathogens (Basel, Switzerland)2025

Acute Influenza Virus-Associated Encephalitis and Other Neurological Complications in Severe Hospitalized Laboratory-Confirmed Influenza Cases-Catalonia 2010-2020.

Pilar Ciruela, Nuria Soldevila, Nuria Torner, Luca Basile, Maria Del Mar Mosquera, M Angeles Marcos, Anna Martínez, Mireia Jané, Cristina Rius, Angela Domínguez and 1 more

Abstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Pilar CiruelaCIBER Epidemiology and Public Health CIBERESP, Instituto de Salud Carlos III, 28029 Madrid, Spain.
Nuria SoldevilaCIBER Epidemiology and Public Health CIBERESP, Instituto de Salud Carlos III, 28029 Madrid, Spain.ORCID 0000-0002-1353-5325
Nuria TornerCIBER Epidemiology and Public Health CIBERESP, Instituto de Salud Carlos III, 28029 Madrid, Spain.ORCID 0000-0003-0143-5295
Luca BasilePublic Health Agency of Catalonia, 08005 Barcelona, Spain.ORCID 0000-0002-4707-2621
Maria Del Mar MosqueraDepartment of Medicine, University of Barcelona, 08036 Barcelona, Spain.ORCID 0000-0001-5863-7424
M Angeles MarcosDepartment of Microbiology, Hospital Clínic of Barcelona-ISGLOBAL, 08036 Barcelona, Spain.
Anna MartínezCIBER Epidemiology and Public Health CIBERESP, Instituto de Salud Carlos III, 28029 Madrid, Spain.
Mireia JanéCIBER Epidemiology and Public Health CIBERESP, Instituto de Salud Carlos III, 28029 Madrid, Spain.
Cristina RiusCIBER Epidemiology and Public Health CIBERESP, Instituto de Salud Carlos III, 28029 Madrid, Spain.
Angela DomínguezCIBER Epidemiology and Public Health CIBERESP, Instituto de Salud Carlos III, 28029 Madrid, Spain.ORCID 0000-0003-0219-1907
The Working Group For The Catalan Influenza And Severe Acute Respiratory Infection Sentinel Surveillance Network Pidirac

Funding

Agència de Gestió d'Ajuts Universitaris i de Recerca 2017/SGR 1342 and 2021/SGR 00702
6 · The paper itself

Abstract

Neurological complications associated with influenza (NCIs) are rare events in adults. Influenza-associated encephalopathy is one of the most severe and frequently reported NCIs. The aim of this study is to describe the frequency and characteristics of NCIs in adults during 10 post-2009 pandemic influenza seasons. Data were obtained from the registry of influenza cases admitted to hospitals of the PIDIRAC network for the surveillance of severe hospitalized laboratory-confirmed influenza (SHLCI) cases in Catalonia from October 2010 to March 2020. The variables analyzed were NCI, age, antiviral treatment, vaccination status, and outcome at discharge. During the study period, 9 (1.5‱) of 5931 SHLCI cases presented NCI. Five (55.6%) had influenza A and four (44.4%) had influenza B. Median age was 62 (17-67) years. One case had been vaccinated, all had received antiviral treatment, and five required ICU admission. The mean length of stay was 25.6 days (SD 25.8). Encephalitis was the most frequent complication, occurring in six cases (66.7%). Of these, three cases (50%) were caused by influenza A (two AH1N1pdm09 strains and one AH3N2). The high frequency of influenza-associated encephalitis caused by both type A and B influenza viruses suggests that both should be considered as potential etiologic factors for encephalopathy and other neurological diseases in adults. This recommendation would allow for the prompt antiviral treatment and prevention of severe outcomes.

Indexed as

EncephalitisEncephalitis, ViralInfluenza, HumanAdolescentAdultAgedAntiviral AgentsFemaleHospitalizationHumansInfluenza B virusMaleMiddle AgedSpainYoung AdultAntiviral Agentsencephalitisinfluenzaneurological complication

Identifiers

PMID40137722
PMCPMC11944371

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.